Literature DB >> 19932286

Metal allergy to Amplatzer occluder device presented as severe bronchospasm.

Reza A Khodaverdian1, Kent W Jones.   

Abstract

Percutaneous closure of an atrial septal defect has become increasingly popular among interventional cardiologists. With this relatively new technology being more widespread, it is important to acknowledge any device-related complications. We report a case of severe bronchospasm secondary to a metal allergy after an atrial septal defect device closure requiring device removal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932286     DOI: 10.1016/j.athoracsur.2009.05.044

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

2.  Closure of interatrial defects by immediate-release patch.

Authors:  Aliakbar Zeinaloo; Keyhan Sayadpour Zanjani; Bahman Rastkar; Alimohammad Hajizeinali; Bahram Sohrabi; Mahmoud Samadi; Eleftherios B Sideris
Journal:  Pediatr Cardiol       Date:  2012-03-28       Impact factor: 1.655

3.  Current practices in corrosion, surface characterization, and nickel leach testing of cardiovascular metallic implants.

Authors:  Srinidhi Nagaraja; Matthew Di Prima; David Saylor; Erica Takai
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2016-02-16       Impact factor: 3.368

4.  Study of biodegradable occluder of atrial septal defect in a porcine model.

Authors:  Bo-Ning Li; Yu-Mei Xie; Zhao-Feng Xie; Xian-Miao Chen; Gui Zhang; De-Yuan Zhang; Xiang-Dong Liu; Zhi-Wei Zhang
Journal:  Catheter Cardiovasc Interv       Date:  2018-09-09       Impact factor: 2.692

Review 5.  Nickel Hypersensitivity to Atrial Septal Occluders: Smoke Without Fire?

Authors:  Anastasios Apostolos; Maria Drakopoulou; Stamatios Gregoriou; Andreas Synetos; George Trantalis; Georgios Tsivgoulis; Spyridon Deftereos; Konstantinos Tsioufis; Konstantinos Toutouzas
Journal:  Clin Rev Allergy Immunol       Date:  2021-06-15       Impact factor: 8.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.